Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KoothLSE:KOO +2.74%70 EV-to-EBITDA is 3.21 as of Aug. 12, 2026, which is 87% below its 10-year median of 23.79. GuruFocus rates LSE:KOO with a GF Score™ of 70/100 and a GF Value™ of £3.96 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 513 Healthcare Providers & Services companies, Kooth ranks better than 94.35% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Kooth's enterprise value is £32.83 Mil.
Kooth's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was £10.23 Mil. Therefore, Kooth's EV-to-EBITDA for today is 3.21.
The historical rank and industry rank for Kooth's EV-to-EBITDA or its related term are showing as below:
LSE:KOO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -691.14 Med: 23.79 Max: 648.01
Current: 3.21
During the past 9 years, the highest EV-to-EBITDA of Kooth was 648.01. The lowest was -691.14. And the median was 23.79.
LSE:KOO's EV-to-EBITDA is ranked better than 94.35% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.9
vs LSE:KOO: 3.21
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-08-12), Kooth's stock price is £1.50.
Kooth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.070. Therefore, Kooth's PE Ratio (TTM) for today is 21.43.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Kooth's share price for today is £1.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kooth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.070.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Kooth's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:KOO vs VEEV, BTSG, HQY: EV-to-EBITDA Comparison
For the Health Information Services subindustry, Kooth's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kooth EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kooth's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Kooth's EV-to-EBITDA falls into.
Kooth's current Enterprise Value is £32.83 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kooth's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was £10.23 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kooth (LSE:KOO) has a EV-to-EBITDA of 3.21 as of Aug. 12, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Kooth. This is 87% below median its historical median of 23.79. According to the industry distribution chart, Kooth ranks #29 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 5.7%.
Is Kooth's EV-to-EBITDA too high?
Kooth's current EV-to-EBITDA of 3.21 is 87% below median its 10-year median of 23.79. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.90. Kooth's value of 3.21 is 70.6% below this industry median. Based on the distribution chart, Kooth ranks #29 out of 513 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Kooth has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kooth's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Kooth ranks #29 out of 513 companies for EV-to-EBITDA. This places Kooth in the top 6% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.90. Kooth's value of 3.21 is 70.6% below this benchmark. While the company's 10-year median is 23.79 vs. the industry median of 10.90, Kooth has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.90, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kooth's current EV-to-EBITDA of 3.21 is 70.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Kooth. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kooth's current EV-to-EBITDA is 3.21, which is 87% below median its own 10-year median of 23.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kooth stock overvalued right now?
Based on GuruFocus' analysis, Kooth (LSE:KOO) is currently considered Significantly Undervalued. The stock's GF Value™ is £3.96, compared to a current price of £1.50 — trading 62.1% below its estimated fair value. The current EV-to-EBITDA is 3.21, which is 87% below median its 10-year median of 23.79 and 70.6% below the Healthcare Providers & Services industry median of 10.90. Kooth's overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Kooth (LSE:KOO), the current EV-to-EBITDA is 3.21 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kooth (LSE:KOO) Overvalued in 2026?
Based on GuruFocus' analysis, Kooth stock appears to be undervalued.
The current stock price of £1.50 is trading 62.1% below its estimated GF Value™ of £3.96.
GuruFocus considers Kooth to be Significantly Undervalued.
Key valuation signals for LSE:KOO:
EV-to-EBITDA: 3.21 (87% below median its 10-year median of 23.79)
GF Value™: £3.96 vs. price of £1.50 (62.1% below fair value)
Industry Position: 70.6% below the Healthcare Providers & Services median (#29 of 513)
No single metric tells the full story. See the LSE:KOO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kooth PLC principal activity of the Group is the provision of online counselling, coaching and support to children, young people, and adults in need. It operates a business-to-business-to consumer model. The group currently operates under two reporting segments being the United Kingdom and United States. The company generates majority of revenue from United States.
70GF Score
Get the complete analysis for LSE:KOO
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:KOO has been successfully added to your 
